Crypto Treasury Revolution: Why a Swedish Health Tech Firm Is Going All-In on Bitcoin Now

Crypto Treasury Revolution: Why a Swedish Health Tech Firm Is Going All-In on Bitcoin Now

Crypto continues to make waves in the corporate finance world as Stockholm-based health tech innovator H100 Group AB has secured $2.2 million through 0% interest convertible loans to supercharge its Bitcoin reserves. The unprecedented move is set to accelerate the firm’s transition into a major European player embracing crypto as a corporate treasury asset—signaling a growing shift among public companies toward blockchain-based financial strategies.

The crypto funding round was anchored by British cryptographer and Bitcoin advocate Adam Back, who contributed a noteworthy $1.4 million. Alongside Back, established investment groups like Morten Klein, Alundo Invest AS, Race Venture Scandinavia AB, and Crafoord Capital Partners brought in a collective $800,000. All eyes are now on how H100 leverages these funds; if executed at current BTC prices, the firm stands to acquire an estimated 20.18 Bitcoin, layering on top of the 4.39 BTC it had already purchased in late May 2024.

Under loan terms, set for maturity in June 2028, investors can convert their loans into equity if the company’s share price performs strongly. Should full conversion occur, over 16 million new shares could be issued, resulting in a potential 12% equity dilution—but also deeper alignment of key stakeholders with H100’s transformative crypto vision.

A Historic First for Sweden and EuropeH100’s initial foray into the Bitcoin space valued at $490,000 established it as the first publicly listed Swedish firm to adopt BTC as a core treasury asset—joining a short, but rapidly expanding, list of European companies adding crypto assets to their balance sheets. Shareholders responded enthusiastically, driving a 39% rally in H100’s stock and catapulting the company’s market valuation beyond $14 million.

[ Bitcoin reclaims $109K as Trump extends EU tariffs deadline to allow for talks ]

This bold crypto move is not an outlier. Public healthcare and tech companies globally are increasingly integrating crypto into their strategies. Notably, Singapore’s Basel Medical Group recently signed a $1 billion deal to purchase up to 10,000 BTC, leveraging its ordinary shares. In the U.S., healthcare provider KindlyMD received shareholder approval for a Bitcoin-centric merger, breaking new ground in blockchain finance.

Canadian firm SRx Health Solutions, meanwhile, also jumped in—declaring plans for Bitcoin acquisitions after an earlier $1.5 million investment in Solana. These examples underscore a worldwide momentum: the trend of corporate crypto treasury allocation shows no signs of slowing down. Learn more about crypto adoption in corporate treasuries in our comprehensive guide on the rise of institutional Bitcoin yields:

Why It Matters for Crypto, Blockchain, and Traditional FinanceAdopting Bitcoin as a treasury asset diversifies company reserves and has the potential to hedge against traditional currency risks—something increasingly important in today’s volatile macro environment. Expert voices across the sector note that such moves can boost corporate resilience and align firms with the future of global finance.

With regulatory clarity around digital assets gradually improving in Europe and Asia, expect other publicly listed companies to watch H100’s experiment closely. Analysts anticipate further announcements as more traditional firms step into the world of digital assets, staking their futures on blockchain technology for long-term strategic advantage.

The trend is clear: crypto and DeFi are transforming how corporates approach cash reserves and risk management. Keeping an eye on innovative companies like H100 could offer a glimpse of the next wave in global financial evolution.

Newsletter Updates

Enter your email address below and subscribe to our newsletter